EBS Return on Tangible Equity | EMERGENT BIOSOLUTIONS INC.

EMERGENT BIOSOLUTIONS INC. (EBS) Return on Tangible Equity

2026-06-30: Return Tang Equity -222.11%.
2026-03-31: Return Tang Equity -16.32%.
2025-12-31: Return Tang Equity 61.09%.
2025-09-30: Return Tang Equity 58.47%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-222.11%
2026-03-31	-16.32%
2025-12-31	61.09%
2025-09-30	58.47%
2025-06-30	207.59%
2025-03-31	-194.96%
2024-12-31	1019.25%
2024-09-30	2221.28%
2024-06-30	397.16%
2024-03-31	-498.06%
2023-12-31	-919.59%
2023-09-30	-680.07%
2023-06-30	-410.16%
2023-03-31	-104.30%
2022-12-31	-48.01%
2022-09-30	6.86%
2022-06-30	12.41%
2022-03-31	19.32%
2021-12-31	28.07%
2021-09-30	35.60%
2021-06-30	46.46%
2021-03-31	63.69%
2020-12-31	58.55%
2020-09-30	54.28%
2020-06-30	71.17%
2020-03-31	67.90%
2019-12-31	50.09%
2019-09-30	10.85%
2019-06-30	83.03%
2019-03-31	-110.67%
2018-12-31	-601.92%
2018-09-30	12.54%
2018-06-30	14.64%
2018-03-31	9.43%
2017-12-31	11.11%
2017-09-30	14.58%
2017-06-30	13.50%
2017-03-31	10.85%
2016-12-31	9.94%
2016-09-30	10.51%
2016-06-30	11.21%
2016-03-31	15.87%
2015-12-31	11.19%
2015-09-30	12.10%
2015-06-30	9.95%
2015-03-31	8.06%
2014-12-31	7.87%
2014-09-30	5.36%
2014-06-30	3.61%
2014-03-31	5.25%
2013-12-31	6.55%
2013-09-30	7.07%
2013-06-30	5.66%
2013-03-31	5.18%
2012-12-31	5.40%
2012-09-30	8.56%
2012-06-30	7.49%
2012-03-31	9.30%
2011-12-31	5.63%
2011-09-30	5.48%
2011-06-30	8.65%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	61.09%
2024-12-31	1019.25%
2023-12-31	-919.59%
2022-12-31	-48.01%
2021-12-31	28.07%
2020-12-31	58.55%
2019-12-31	50.00%
2018-12-31	-602.88%
2017-12-31	11.11%
2016-12-31	9.94%
2015-12-31	11.19%
2014-12-31	7.87%
2013-12-31	6.55%
2012-12-31	5.40%
2011-12-31	5.63%
2010-12-31	14.20%
2009-12-31	12.77%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)	United States	$0.349B	-6.72
Larimar Therapeutics, Inc. (LRMR)	United States	$0.344B	-1.83
Vogenx, Inc. (VOGX)	United States	$0.355B
Benitec Biopharma Inc. (BNTC)	United States	$0.337B	-10.08
BioAge Labs, Inc. (BIOA)	United States	$0.333B	-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)	United States	$0.320B	-3.35
Evommune, Inc. (EVMN)	United States	$0.320B	-5.10
Prelude Therapeutics Inc (PRLD)	United States	$0.318B	-7.01
ABEONA THERAPEUTICS INC. (ABEO)	United States	$0.312B	-5.63
Rezolute, Inc. (RZLT)	United States	$0.382B	-6.45